A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (SWOG S1400)

  • STATUS
    Recruiting
Updated on 23 November 2020
lung cancer
squamous cell lung cancer

Summary

A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (SWOG S1400)

Description

Squamous NSCLC (any stage); at least one platinum-based line of chemo; Tx on sub-studies based on central lab biomarker testing. The Lung-MAP study is a large clinical trial that is testing new treatments for patients who have advanced-stage squamous cell lung cancer. There are many different changes to a person’s cancer genes that can cause squamous cells to grow out of control. Researchers have developed new drugs that might “target” these genetic changes better and with fewer side effects. The Lung-MAP study hopes to learn if the drugs that target the genetic changes in the cancer cells will slow or stop the squamous cell lung cancer from growing.

Details
Condition Lung Cancer
Clinical Study IdentifierTX149724
Last Modified on23 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Gender: Male or Female
Do you have any of these conditions: Do you have Lung Cancer??
Only you and your doctor can decide if Lung-MAP is right for you
Eligible patients have been diagnosed with advanced-squamous lung cancer, and have received at least one dose of chemotherapy
Lung-MAP patients must be at least 18 years old
Ask your doctor about Lung-MAP, also known as S1400
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note